申请人:USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I.
公开号:US20220185822A1
公开(公告)日:2022-06-16
A structurally novel class of heterocyclic compounds of general formula I wherein L1 is heteroaryl and L2 is heteroaryl or aryl is disclosed. The novel compounds are useful in a method of prevention or treatment of a condition that is mediated by the action, or by loss of action of Constitutive androstane receptor (CAR) receptor or its endogenous ligands. The present invention provides the novel compounds for medicinal use as well as pharmaceutical composition containing the compounds.